CGON
Price
$25.94
Change
-$0.28 (-1.07%)
Updated
May 22, 12:28 PM (EDT)
Capitalization
2B
77 days until earnings call
VERA
Price
$19.88
Change
-$0.51 (-2.50%)
Updated
May 22, 12:59 PM (EDT)
Capitalization
1.35B
77 days until earnings call
Interact to see
Advertisement

CGON vs VERA

Header iconCGON vs VERA Comparison
Open Charts CGON vs VERABanner chart's image
CG Oncology
Price$25.94
Change-$0.28 (-1.07%)
Volume$1K
Capitalization2B
Vera Therapeutics
Price$19.88
Change-$0.51 (-2.50%)
Volume$1.41K
Capitalization1.35B
CGON vs VERA Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. VERA commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CGON: $26.22 vs. VERA: $20.39)
Brand notoriety: CGON and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 75% vs. VERA: 58%
Market capitalization -- CGON: $2B vs. VERA: $1.35B
CGON [@Biotechnology] is valued at $2B. VERA’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGON and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 3 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 5 bearish.
  • VERA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CGON is a better buy in the short-term than VERA.

Price Growth

CGON (@Biotechnology) experienced а +8.48% price change this week, while VERA (@Biotechnology) price change was -3.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2B) has a higher market cap than VERA($1.36B). CGON YTD gains are higher at: -8.577 vs. VERA (-51.785). CGON has higher annual earnings (EBITDA): -95.94M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. CGON (541M). CGON has less debt than VERA: CGON (296K) vs VERA (54.5M). CGON has higher revenues than VERA: CGON (684K) vs VERA (0).
CGONVERACGON / VERA
Capitalization2B1.36B148%
EBITDA-95.94M-167.77M57%
Gain YTD-8.577-51.78517%
P/E RatioN/AN/A-
Revenue684K0-
Total Cash541M590M92%
Total Debt296K54.5M1%
TECHNICAL ANALYSIS
Technical Analysis
CGONVERA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UIISX18.00N/A
N/A
Victory Income Stock Institutional
IRLUX41.90N/A
N/A
Voya Russell Large Cap Index Port S2
EAISX16.10N/A
N/A
Parametric International Equity A
PFGEX26.08N/A
N/A
Parnassus Growth Equity Investor
MSDVX19.76-0.37
-1.84%
BlackRock Equity Dividend Svc

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.28%
IDYA - CGON
57%
Loosely correlated
-2.45%
ACLX - CGON
57%
Loosely correlated
+8.26%
SYRE - CGON
56%
Loosely correlated
-4.03%
RCKT - CGON
56%
Loosely correlated
-3.80%
KYMR - CGON
56%
Loosely correlated
-4.17%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with CRNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-4.00%
CRNX - VERA
47%
Loosely correlated
-4.53%
XNCR - VERA
45%
Loosely correlated
-7.62%
CGON - VERA
45%
Loosely correlated
-1.28%
ROIV - VERA
43%
Loosely correlated
-1.18%
ATXS - VERA
43%
Loosely correlated
-8.62%
More